Literature DB >> 17349572

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Yimin Ge1, Mahmoud A Eltorky, Randy D Ernst, Claudia Y Castro.   

Abstract

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia is an extremely rare pulmonary lesion, with only 39 cases reported in the literature. We report an additional case and review the literature. The patient is a 41-year-old man with a 5-year history of progressive dyspnea, cough, and wheezing. He was initially diagnosed as having bronchial asthma but did not respond to treatment of bronchodilators and inhaled steroids. Pulmonary function tests showed airflow obstruction. Chest computed tomography revealed a mosaic pattern of air trapping and thickening of bronchial walls. Open lung biopsy showed diffuse proliferation of pulmonary neuroendocrine cells within the bronchiolar epithelium, often bulging into or obliterating the bronchiolar lumen. These cells also breached the basement membrane, forming tumorlets. There was prominent peribronchiolar fibrosis and obliterative bronchiolitis. The pathologic evaluation of lung tissue is currently the gold standard in making a definitive diagnosis of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, and all the reported cases were diagnosed by either open lung biopsy or lobectomy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17349572     DOI: 10.1016/j.anndiagpath.2005.12.008

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  5 in total

1.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with a central and peripheral carcinoid and multiple tumorlets: a case report emphasizing the role of neuropeptide hormones and human gonadotropin-alpha.

Authors:  Hanako Oba; Kazunori Nishida; Shingo Takeuchi; Hirohiko Akiyama; Koji Muramatsu; Masafumi Kurosumi; Toru Kameya
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

2.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series.

Authors:  Aman Chauhan; Robert A Ramirez
Journal:  Lung       Date:  2015-06-26       Impact factor: 2.584

3.  Diffuse intrapulmonary neuroendocrine cell hyperplasia.

Authors:  Anna Louise McGuire; Donna E Maziak; Harman S Sekhon
Journal:  Can Respir J       Date:  2013-09-12       Impact factor: 2.409

4.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review of the Literature and a Single-center Experience.

Authors:  Luis Cabezón-Gutiérrez; Parham Khosravi-Shahi; Magda Palka-Kotlowska; Sara Custodio-Cabello; Maria García-Martos
Journal:  Cureus       Date:  2019-09-13

5.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in association with an adenocarcinoma: a case report.

Authors:  Arne Warth; Esther Herpel; Astrid Schmähl; Konstantina Storz; Philipp A Schnabel
Journal:  J Med Case Rep       Date:  2008-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.